Briefs: IOL Chemicals & Pharmaceuticals, Goa Carbon and Kamron Laboratories
Chemical

Briefs: IOL Chemicals & Pharmaceuticals, Goa Carbon and Kamron Laboratories

The rating agency has reaffirmed the outlook of Goa Carbon as 'Stable'.

  • By ICN Bureau | October 15, 2021

IOL Chemicals & Pharmaceuticals receives Korean FDA approval

IOL Chemicals & Pharmaceuticals Ltd has received approval of Korean Ministry of Food and Drug Safety (Korean FDA) for Company's Pharmaceuticals API products 'IBUPROFEN and 'FENOFIBRATE'. The approval of Korean FDA re-establishes the Company's efforts to keep the highest quality standards and to increase presence in the regulated markets. This will strengthen Company's presence in South Korean market.

Acuite reaffirms rating of Goa Carbon

Acuite Ratings & Research Limited has reviewed and reaffirmed the long term rating of 'ACUITE BBB- ' and the short term rating of 'ACUITE A3+' on the 273.00 crore bank facilities of Goa Carbon Limited. Further, Acuite has reaffirmed the outlook as 'Stable'.

Kamron Laboratories is now Adline Chem Lab

Kamron Laboratories Limited has received from the Registrar of Companies, Gujarat (ROC), the Certificate of Incorporation pursuant to change of name dated 13th October, 2021 certifying that the name of the Company has been changed from Kamron Laboratories Limited to ADLINE CHEM LAB LIMITED with effect from the date of certificate and that the company is limited by shares.

Register Now to Attend E-Conference on Digital Transformation: The Catalyst for Agile and Smarter Process R&D on June 4 at 3:00 - 4:30 PM IST

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2025 on June 18-19th 2025, The Leela Mumbai

Other Related stories

Startups

Petrochemical

Energy

Digitization